Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells – a potential mechanism for targeting liver anti-fibrotic therapeutics
- 30 June 2005
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 42 (6), 888-896
- https://doi.org/10.1016/j.jhep.2005.01.028
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cellsHepatology, 2004
- History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate CellsSeminars in Liver Disease, 2001
- Hepatic Stellate Cells as a Target for the Treatment of Liver FibrosisSeminars in Liver Disease, 2001
- Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in ratsGastroenterology, 2001
- Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factorsGut, 2001
- Drug targetingEuropean Journal of Pharmaceutical Sciences, 2000
- Successful Targeting to Rat Hepatic Stellate Cells Using Albumin Modified with Cyclic Peptides That Recognize the Collagen Type VI ReceptorJournal of Biological Chemistry, 2000
- Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue InjuryJournal of Biological Chemistry, 2000
- Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cellsHepatology, 1999
- Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.JCI Insight, 1998